XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Total revenue $ 10,724 $ 9,033
Cost of sales 7,378 6,754
Gross profit 3,346 2,279
Operating expenses:    
Selling, general and administrative 14,666 11,985
Research and development 3,494 4,850
Total operating expenses 18,160 16,835
Loss from operations (14,814) (14,556)
Interest and financing costs, net (557) (966)
Loss before income tax expense (15,371) (15,522)
Net loss (15,371) (15,522)
Other comprehensive income (net of tax):    
Unrealized gain on short-term investments 56  
Comprehensive loss $ (15,315) $ (15,522)
Net loss per share - basic $ (0.16) $ (0.59)
Net loss per share - diluted $ (0.16) $ (0.59)
Weighted-average shares outstanding - basic 93,391,444 26,405,252
Weighted-average shares outstanding - diluted 93,391,444 26,405,252
Product    
Total revenue $ 8,678 $ 7,203
Cost of sales 6,700 6,078
Gross profit 1,978 1,125
Operating expenses:    
Selling, general and administrative 14,114 11,526
Research and development 2,927 4,431
Total operating expenses 17,041 15,957
Loss from operations (15,063) (14,832)
Software    
Total revenue 2,046 1,830
Cost of sales 678 676
Gross profit 1,368 1,154
Operating expenses:    
Selling, general and administrative 552 459
Research and development 567 419
Total operating expenses 1,119 878
Loss from operations $ 249 $ 276